Cytokines 2019, October 20-23, 2019, Hofburg Conference Center, Vienna, Austria
Cytokines & Interferons: From Biology to Clinics

Cytokine targeting has become one of the greatest revolutions in modern medicine. A large number of severe and sometimes even lethal inflammatory and autoimmune diseases have become manageable due to selective inhibition of cytokines and cytokine signaling. The development of compounds that selectively inhibit cytokines or interferons has permitted an so far unprecedented molecular characterization of human disease. Cytokines also contribute to cancer development and alterations in tissue homeostasis. Cytokines 2019 will address these developments and provide a comprehensive picture of the current knowledge of cytokine pathways in human disease and the strategies to inhibit, modulate or foster cytokine responses.

Topics – The Following specific topics will be addressed:

                • Mechanisms and treatment of skin inflammation: The IL-23/IL-17 pathway

                • Biology and targeting of type 2-mediated immune responses in the skin and lungs

                • Pro-resolving and immune-regulatory cytokines: Control of inflammation and autoimmunity

                • Local and systemic effects of IL-1 family cytokines in disease

                • The biology of IL-6 and the role of IL-6 inhibition in disease

                • Type I interferons: biology and their role in disease

                • Immune metabolism regulating cytokine production and immune cell polarization

                • Therapeutic targeting of the cytokine signaling pathways

                • Cytokine-related diseases after checkpoint inhibition

                • Cytokine-mediated resident tissue destruction and fibrotic responses

                • Control of intestinal and joint inflammation by inflammatory cytokines

                • Cytokine effects on the brain: molecular control of pain, sickness behavior and depression

                • Targeting neutrophils and macrophagesin immune-mediated disease

                • Induction of immune tolerance –fact or fiction?


Approximately 80 travel awards will be made available to qualifying abstract presenters, as well as multiple Young Investigator Awards. The Abstract/Awards application deadline is 1 June, 2019. For more information: